- Home
- OGI vs SGHT Comparison
OGI vs SGHT Comparison
Compare OGI & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- SGHT
- Stock Information
- Founded
- OGI 2013
- SGHT 2011
- Country
- OGI Canada
- SGHT United States
- Employees
- OGI N/A
- SGHT N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- SGHT Medical Specialities
- Sector
- OGI Health Care
- SGHT Health Care
- Exchange
- OGI Nasdaq
- SGHT Nasdaq
- Market Cap
- OGI 204.8M
- SGHT 179.7M
- IPO Year
- OGI N/A
- SGHT 2021
- Fundamental
- Price
- OGI $1.43
- SGHT $4.20
- Analyst Decision
- OGI
- SGHT Buy
- Analyst Count
- OGI 0
- SGHT 8
- Target Price
- OGI N/A
- SGHT $4.16
- AVG Volume (30 Days)
- OGI 922.1K
- SGHT 127.2K
- Earning Date
- OGI 08-13-2025
- SGHT 08-07-2025
- Dividend Yield
- OGI N/A
- SGHT N/A
- EPS Growth
- OGI N/A
- SGHT N/A
- EPS
- OGI 0.05
- SGHT N/A
- Revenue
- OGI $164,107,753.00
- SGHT $76,303,000.00
- Revenue This Year
- OGI $55.39
- SGHT N/A
- Revenue Next Year
- OGI $14.40
- SGHT $11.22
- P/E Ratio
- OGI $29.40
- SGHT N/A
- Revenue Growth
- OGI 50.01
- SGHT N/A
- 52 Week Low
- OGI $0.85
- SGHT $2.03
- 52 Week High
- OGI $2.08
- SGHT $7.05
- Technical
- Relative Strength Index (RSI)
- OGI 47.68
- SGHT 61.53
- Support Level
- OGI $1.30
- SGHT $4.01
- Resistance Level
- OGI $1.69
- SGHT $4.34
- Average True Range (ATR)
- OGI 0.08
- SGHT 0.24
- MACD
- OGI 0.01
- SGHT 0.09
- Stochastic Oscillator
- OGI 33.33
- SGHT 88.62
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.